China
· Delayed Price · Currency is CNY Guangzhou Kingmed Diagnostics Group Statistics
Total Valuation
Guangzhou Kingmed Diagnostics Group has a market cap or net worth of CNY 18.40 billion. The enterprise value is 17.49 billion.
| Market Cap | 18.40B |
| Enterprise Value | 17.49B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 18, 2024 |
Share Statistics
Guangzhou Kingmed Diagnostics Group has 464.79 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Shares Outstanding | 464.79M |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | +2.54% |
| Owned by Insiders (%) | 17.61% |
| Owned by Institutions (%) | 37.63% |
| Float | 332.75M |
Valuation Ratios
The trailing PE ratio is 41.40 and the forward PE ratio is 30.11. Guangzhou Kingmed Diagnostics Group's PEG ratio is 2.01.
| PE Ratio | 41.40 |
| Forward PE | 30.11 |
| PS Ratio | 2.25 |
| PB Ratio | 2.41 |
| P/FCF Ratio | 65.87 |
| PEG Ratio | 2.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.49, with an EV/FCF ratio of 62.59.
| EV / Earnings | 39.02 |
| EV / Sales | 2.12 |
| EV / EBITDA | 24.49 |
| EV / EBIT | 115.32 |
| EV / FCF | 62.59 |
Financial Position
The company has a current ratio of 2.96, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.96 |
| Quick Ratio | 2.81 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.98 |
| Debt / FCF | 2.52 |
| Interest Coverage | 8.05 |
Financial Efficiency
Return on equity (ROE) is 5.34% and return on invested capital (ROIC) is 1.08%.
| Return on Equity (ROE) | 5.34% |
| Return on Assets (ROA) | 0.81% |
| Return on Capital (ROIC) | 1.08% |
| Revenue Per Employee | 712,154 |
| Profits Per Employee | 38,684 |
| Employee Count | 11,586 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 21.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.62% in the last 52 weeks. The beta is 0.66, so Guangzhou Kingmed Diagnostics Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -40.62% |
| 50-Day Moving Average | 28.95 |
| 200-Day Moving Average | 42.24 |
| Relative Strength Index (RSI) | 67.28 |
| Average Volume (20 Days) | 8,148,587 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Guangzhou Kingmed Diagnostics Group had revenue of CNY 8.25 billion and earned 448.19 million in profits. Earnings per share was 0.96.
| Revenue | 8.25B |
| Gross Profit | 2.93B |
| Operating Income | 151.64M |
| Pretax Income | 511.24M |
| Net Income | 448.19M |
| EBITDA | 595.81M |
| EBIT | 151.64M |
| Earnings Per Share (EPS) | 0.96 |
Balance Sheet
The company has 1.79 billion in cash and 702.68 million in debt, giving a net cash position of 1.09 billion or 2.35 per share.
| Cash & Cash Equivalents | 1.79B |
| Total Debt | 702.68M |
| Net Cash | 1.09B |
| Net Cash Per Share | 2.35 |
| Equity (Book Value) | 8.02B |
| Book Value Per Share | 16.42 |
| Working Capital | 5.22B |
Cash Flow
In the last 12 months, operating cash flow was 911.47 million and capital expenditures -632.10 million, giving a free cash flow of 279.37 million.
| Operating Cash Flow | 911.47M |
| Capital Expenditures | -632.10M |
| Free Cash Flow | 279.37M |
| FCF Per Share | 0.60 |
Margins
Gross margin is 35.54%, with operating and profit margins of 1.84% and 5.43%.
| Gross Margin | 35.54% |
| Operating Margin | 1.84% |
| Pretax Margin | 6.20% |
| Profit Margin | 5.43% |
| EBITDA Margin | 7.22% |
| EBIT Margin | 1.84% |
| FCF Margin | 3.39% |
Dividends & Yields
This stock pays an annual dividend of 0.88, which amounts to a dividend yield of 2.44%.
| Dividend Per Share | 0.88 |
| Dividend Yield | 2.44% |
| Dividend Growth (YoY) | -50.56% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 93.34% |
| Buyback Yield | -0.38% |
| Shareholder Yield | 2.06% |
| Earnings Yield | 2.42% |
| FCF Yield | 1.52% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Guangzhou Kingmed Diagnostics Group has an Altman Z-Score of 6.91.
| Altman Z-Score | 6.91 |
| Piotroski F-Score | n/a |